BIOMAT Database Logo BIOMAT Database Logo

[Indication and results of hematopoietic stem cell transplantation. 5. Solid tumor]. 1998

C Shimazaki, and M Nakagawa

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell

Related Publications

C Shimazaki, and M Nakagawa
[Indication and results of hematopoietic stem cell transplantation. 1. Acute leukemia].
August 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
C Shimazaki, and M Nakagawa
[Indication and results of hematopoietic stem cell transplantation. 2. Chronic myelogenous leukemia].
August 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
C Shimazaki, and M Nakagawa
[Indication and results of hematopoietic stem cell transplantation. 3. Aplastic anemia and myelodysplastic syndrome].
August 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
C Shimazaki, and M Nakagawa
[Indication and results of hematopoietic stem cell transplantation. 4. Malignant lymphoma and multiple myeloma].
August 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
C Shimazaki, and M Nakagawa
[Secondary solid tumor and late mortality after allogeneic hematopoietic stem cell transplantation].
July 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology,
C Shimazaki, and M Nakagawa
[Indication and outcomes of hematopoietic stem cell transplantation for MDS].
April 2012, Nihon rinsho. Japanese journal of clinical medicine,
C Shimazaki, and M Nakagawa
Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies.
June 2022, Stem cells (Dayton, Ohio),
C Shimazaki, and M Nakagawa
[Allogeneic hematopoietic stem cell transplantation for solid tumors].
March 2004, [Rinsho ketsueki] The Japanese journal of clinical hematology,
C Shimazaki, and M Nakagawa
Hematopoietic stem cell transplantation for follicular lymphoma: optimal timing and indication.
January 2014, Journal of clinical and experimental hematopathology : JCEH,
C Shimazaki, and M Nakagawa
Desensitization for solid organ and hematopoietic stem cell transplantation.
March 2014, Immunological reviews,
Copied contents to your clipboard!